Comparison of PRS According to Inhalation Agent During LDLT

NCT01886664 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Postreperfusion Syndrome

Interventions

DRUG: sevoflurane
DRUG: Desflurane

Sponsor

Seoul National University Hospital